Discounted Cash Flow (DCF) Analysis Unlevered

IntegraGen SA (ALINT.PA)

0.95 €

-0.03 (-3.06%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 0.95 | undervalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 6.928.288.9811.3213.1715.4918.2121.4225.1929.63
Revenue (%)
EBITDA -1.06-0.04-0.040.060.07-0.47-0.55-0.65-0.77-0.90
EBITDA (%)
EBIT -1.06-0.04-0.040.060.07-0.47-0.55-0.65-0.77-0.90
EBIT (%)
Depreciation ----------
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 4.012.815.124.784.516.988.219.6511.3513.35
Total Cash (%)
Account Receivables -2.592.813.554.124.855.716.717.899.28
Account Receivables (%)
Inventories 0.380.290.240.340.390.540.640.750.891.04
Inventories (%)
Accounts Payable 1.550.700.901.771.612.132.502.943.464.07
Accounts Payable (%)
Capital Expenditure ----------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.95
Beta 0.180
Diluted Shares Outstanding 6.63
Cost of Debt
Tax Rate 97.56
After-tax Cost of Debt 0.10%
Risk-Free Rate
Market Risk Premium
Cost of Equity 4.987
Total Debt 1.67
Total Equity 6.30
Total Capital 7.97
Debt Weighting 20.98
Equity Weighting 79.02
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 6.928.288.9811.3213.1715.4918.2121.4225.1929.63
EBITDA -1.06-0.04-0.040.060.07-0.47-0.55-0.65-0.77-0.90
EBIT -1.06-0.04-0.040.060.07-0.47-0.55-0.65-0.77-0.90
Tax Rate 14.47%34.96%19.77%113.48%97.56%56.05%56.05%56.05%56.05%56.05%
EBIAT -0.90-0.03-0.03-0.010-0.21-0.24-0.29-0.34-0.40
Depreciation ----------
Accounts Receivable ---0.22-0.73-0.58-0.73-0.85-1-1.18-1.39
Inventories -0.090.05-0.10-0.05-0.16-0.10-0.11-0.13-0.16
Accounts Payable --0.840.200.87-0.170.520.370.440.520.61
Capital Expenditure ----------
UFCF -0.90-0.78-00.02-0.79-0.57-0.82-0.96-1.13-1.33
WACC
PV UFCF -0.55-0.76-0.86-0.97-1.10
SUM PV UFCF -4.23

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -1.36
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -0.79
Equity Value -
Shares Outstanding 6.63
Equity Value Per Share -